Your browser doesn't support javascript.
DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.
Frank, Mayu O; Blachere, Nathalie E; Parveen, Salina; Hacisuleyman, Ezgi; Fak, John; Luna, Joseph M; Michailidis, Eleftherios; Wright, Samara; Stark, Pamela; Campbell, Ann; Foo, Ashley; Sakmar, Thomas P; Huffman, Virginia; Bergh, Marissa; Goldfarb, Audrey; Mansisidor, Andres; Patriotis, Agata L; Palmquist, Karl H; Poulton, Nicolas; Leicher, Rachel; Vargas, César D M; Duba, Irene; Hurley, Arlene; Colagreco, Joseph; Pagane, Nicole; Orange, Dana E; Mora, Kevin; Rakeman, Jennifer L; Fowler, Randal C; Fernandes, Helen; Lamendola-Essel, Michelle F; Didkovsky, Nicholas; Silvera, Leopolda; Masci, Joseph; Allen, Machelle; Rice, Charles M; Darnell, Robert B.
  • Frank MO; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Blachere NE; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Parveen S; Howard Hughes Medical Institute, The Rockefeller University, New York, NY, United States of America.
  • Hacisuleyman E; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Fak J; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Luna JM; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Michailidis E; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Wright S; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, United States of America.
  • Stark P; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, United States of America.
  • Campbell A; Child and Family Center, The Rockefeller University, New York, NY, United States of America.
  • Foo A; Child and Family Center, The Rockefeller University, New York, NY, United States of America.
  • Sakmar TP; Occupational Health Services, The Rockefeller University, New York, NY, United States of America.
  • Huffman V; Occupational Health Services, The Rockefeller University, New York, NY, United States of America.
  • Bergh M; Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, United States of America.
  • Goldfarb A; Human Resources, The Rockefeller University, New York, NY, United States of America.
  • Mansisidor A; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Patriotis AL; Laboratory of Cell Biology and Genetics, The Rockefeller University, New York, NY, United States of America.
  • Palmquist KH; Laboratory of Genome Architecture and Dynamics, The Rockefeller University, New York, NY, United States of America.
  • Poulton N; Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY, United States of America.
  • Leicher R; Laboratory of Morphogenesis, The Rockefeller University, New York, NY, United States of America.
  • Vargas CDM; Laboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, United States of America.
  • Duba I; Laboratory of Nanoscale Biophysics and Biochemistry, The Rockefeller University, New York, NY, United States of America.
  • Hurley A; Laboratory of Neurogenetics of Language, The Rockefeller University, New York, NY, United States of America.
  • Colagreco J; Laboratory of Genome Architecture and Dynamics, The Rockefeller University, New York, NY, United States of America.
  • Pagane N; Rockefeller University Hospital, The Rockefeller University, New York, NY, United States of America.
  • Orange DE; Leonard Wagner Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY, United States of America.
  • Mora K; Laboratory of Genome Architecture and Dynamics, The Rockefeller University, New York, NY, United States of America.
  • Rakeman JL; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Fowler RC; Hospital for Special Surgery, New York, NY, United States of America.
  • Fernandes H; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Lamendola-Essel MF; Public Health Laboratory, New York City Department of Health and Health and Mental Hygiene, New York, NY, United States of America.
  • Didkovsky N; Public Health Laboratory, New York City Department of Health and Health and Mental Hygiene, New York, NY, United States of America.
  • Silvera L; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Masci J; Department of Pathology and Cell Biology, Columbia University, New York, NY, United States of America.
  • Allen M; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
  • Rice CM; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.
  • Darnell RB; Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America.
PLoS One ; 16(6): e0252949, 2021.
Article in English | MEDLINE | ID: covidwho-1282295
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature up to seven days after sample collection, and safety studies demonstrated that DRUL buffer immediately inactivated virus at concentrations up to 2.75x106 PFU/ml. Results from SARS-CoV-2 positive nasopharyngeal (NP) swab samples collected in viral transport media and assayed with a standard FDA Emergency Use Authorization (EUA) test were highly correlated with samples placed in DRUL buffer. Direct comparison of results from 162 individuals tested by FDA EUA oropharyngeal (OP) or NP swabs with co-collected saliva samples identified four otherwise unidentified positive cases in DRUL buffer. Over six months, we collected 3,724 samples from individuals ranging from 3 months to 92 years of age. This included collecting weekly samples over 10 weeks from teachers, children, and parents from a pre-school program, which allowed its safe reopening while at-risk pods were quarantined. In sum, we validated a simple, sensitive, stable, and safe PCR-based test using a self-collected saliva sample as a valuable tool for clinical diagnosis and screening at workplaces and schools.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Saliva / Schools / Specimen Handling / COVID-19 Nucleic Acid Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Child / Female / Humans / Male Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0252949

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Saliva / Schools / Specimen Handling / COVID-19 Nucleic Acid Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Child / Female / Humans / Male Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0252949